NewsBenzinga헬렌 오브 트로이, 2분기 실적 부진 예상···가장 정확한 애널리스트들, 실적 발표 전 전망 수정 헬렌 오브 트로이, 2분기 실적 부진 예상···가장 정확한 애널리스트들, 실적 발표 전 전망 수정 Benzinga 2026.09.25 07:06 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report